HealthPhoto: DocWireNewsInternational Cost Efficiency of HS Biologic Therapies Compared
The cost of biologic therapies for hidradenitis suppurativa (HS) poses a major challenge for patients and healthcare systems globally. This comparison highlights the variations in cost efficiency of these treatments across different countries, emphasizing the financial burden and access issues faced by those affected by HS worldwide.
DocWireNews·



